Poland· PL-100468223
Atarax
A hydroxyzine product containing hydroxyzini hydrochloridum, registered in Poland by InPharm Sp. z o.o.. The same ATC class is registered in 15 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Hydroxyzine is registered in 15 of 19 countries.
Countries holding a registration under ATC N05BB01 (hydroxyzine), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 8 of them publish a price we can compare per daily dose
Hydroxyzine · ATC N05BB01
15 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of hydroxyzine costs, country by country.
Normalised to the WHO defined daily dose (75 mg), the median price runs from $0.16 in United States to $1.68 in Switzerland — a ×11 gap.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
- US figures are pharmacy acquisition cost (CMS NADAC), not retail
Hydroxyzine · price per daily dose (75 mg)
USD · FX 28 Sept 2026
- CH Switzerland$1.68
- US United States$0.16 (acquisition cost)
The record
At a glance
URPL (Poland)- Active substance
- Hydroxyzini hydrochloridum
- Manufacturer
- InPharm Sp. z o.o.
- Country
- Poland (PL)
- ATC code
- N05BB01
- ATC class
- Hydroxyzine
- Defined daily dose
- 75 mg, O
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
- gtin05909991482459
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
410 interactions on record for hydroxyzine.
Graded by severity as the source publishes them — 46 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Hydroxyzine · interactions on record
410 records
- 46 severe
- 199 moderate
- 5 minor
- 160 info
Most severe, free to view
- PapaverineA03AD01severe
- CisaprideA03FA02severe
- DolasetronA04AA04severe
- Potassium chlorideA12BA01severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Hydroxyzine in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesHydroxyzine hydrochlorideBryant Ranch Prepack
- FranceATARAX 25 mg, comprimé pelliculé sécableUCB PHARMA
- SwedenAtarax 25 mg Filmdragerad tablettUCB Nordic A/S
- FinlandAtaraxUCB Pharma Oy Finland
- SpainATARAX 25 mg COMPRIMIDOS RECUBIERTOS CON PELICULAUcb Pharma S.A.
- NorwayAtaraxUCB Nordic A/S
- IcelandAtaraxUCB Nordic A/S
- IrelandHydroxyzine hydrochloride 25 mg film-coated tabletsBrillpharma (Ireland) Limited
Authorised across Europe · EMA
The same active substance is authorised in 22 EEA countries. Names it is sold under:
- Austria · Atarax, Hydroxyzin Bluefish
- Belgium · Atarax
- Bulgaria · Атаракс, Неуролакс
- Cyprus · Atarax
- Czechia · Atarax
- Germany · Atarax, Hydroxyzin Bluefish
- Denmark · Hydroxyzine Bluefish, Hydroxyzine Medical Valley
- Spain · Atarax, Hidroxizina Bluefish
- Finland · Atarax, Hydroxyzine Orifarm
- France · Atarax, Hydroxyzine Arrow
- United Kingdom (Northern Ireland) · Atarax, Hydroxyzine Hydrochloride 25mg
- Greece · Atarax, Efidac
- Hungary · Atarax
- Ireland · Hydroxyzine Hydrochloride Brillpharma (Ireland)
- Iceland · Atarax, Hydroxyzine Bluefish
- Italy · Atarax
- Luxembourg · Atarax
- Netherlands · Hydroxyzine-2hcl Ucb Pharma
- Norway · Atarax, Hydroxyzine Bluefish
- Portugal · Atarax, Fenartix
- Sweden · Atarax, Hydroxizin Omet Pharma
- Slovakia · Atarax
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/a390c4b3-c349-46ae-aa36-84cc3f6dcfd4 GET /v1/drugs/a390c4b3-c349-46ae-aa36-84cc3f6dcfd4?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki powlekane",
"source": "urpl",
"strength": "25 mg",
"packaging": "05909991482459 ¦ Rp ¦ 144897\n25 tabl.",
"substance": "Hydroxyzini hydrochloridum 25 mg",
"common_name": "Hydroxyzini hydrochloridum",
"pl_product_id": "100468223",
"pozwolenie_nr": "195/22",
"auth_procedure": "IR",
"authorisation_validity": "2027-05-06"
}See everything about hydroxyzine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.